Breast products actually induce breast cancer
Nowadays, many breast products to “touch of the change” and “give you an attractive curve” and other advertisements to attract the females. However, clinical observations indicate that the abuse of hormones breast products may increase breast cancer incidence.
It is understood that the incidence of breast cancer and breast tissue exposure to estrogen inside the time-dependent. Current medical science has confirmed that once the female hormone imbalance in the body, especially the excessive secretion of estrogen, the breast duct epithelial cells will be stimulated by estrogen, from normal development to abnormal proliferation, thereby to cancer.
Experts tell us that external breast contains estrogen products are generally components, if does not contain estrogen, it is difficult to obtain the “visible” effects of the breast. Estrogen excess, not only adversely affect the right breast, but also cause endocrine disorders, such as irregular menstruation, localized pigmentation. If you want to use breast products, doctors recommend women: prior to use, it is best to conduct a detailed examination of the breast to see if there are hidden lesions can not be used blindly. If the original breast there is a potential, small lesions, breast products containing hormones will lead to undesirable consequences. In addition, most breast when the product will coupled with massage, this will speed up the growth rate of lesion and lead to tumor metastasis.
Want to chest fullness, it should be taken during the development of a number of measures. For example, increasing physical activity, dietary protein intake increased attention, doing chest massage in order to promote the development of the mammary gland. An adult, and no special effects approach. Doctors believe that, frequent use of breast product, is likely to be caused by one of the main high incidence of breast cancer. In addition, long-term excessive use of estrogen-containing nutritional supplements, it will also increase the risk of breast cancer risk.